Literature DB >> 6117465

The use of beta blockers for the reduction of mortality after myocardial infarction.

J R Hampton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6117465     DOI： 10.1093/oxfordjournals.eurheartj.a061206

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

Review 1.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 2.  Beta adrenoceptor antagonists after myocardial infarction--where are we now?

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1983-02

3.  Beta-blockade after myocardial infarction--a statistical view.

Authors:  J A Lewis
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Confidence in results of beta-blocker postinfarction trials.

Authors:  N S Baber; J A Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-12

Review 5.  The large studies in hypertension: what have they shown?

Authors:  J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

6.  Labetalol: the nineteen-eighties.

Authors:  J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

7.  Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.

Authors:  T Gundersen
Journal:  Br Heart J       Date:  1983-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.